Clinical Trial Update: 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating 68-Ga-RM2 PET/MRI for imaging estrogen receptor-positive breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• 68-Ga-RM2 (68-Ga-RM2)

Snippet

Sponsor: Andrei Iagaru | Conditions: Breast Carcinoma, Estrogen Receptor Positive | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-13